Concert Pharmaceuticals Inc. | Key People and Executives
Roger D. Tung
President, Chief Executive Officer & Director
Christine van Heek
Independent Director
Meghan M. Fitzgerald
Independent Director
Thomas G. Auchincloss
Independent Director
Wilfred E. Jaeger
Independent Director
Ronald W. Barrett
Independent Director
Peter Barton Hutt
Independent Director
Wendell D. Wierenga
Independent Director
Roger D. Tung
President, Chief Executive Officer & Director
Nancy Stuart
Chief Operating Officer
Marc Becker
Chief Financial Officer
Scott Weintraub
Vice President-Commercial & Product Strategy
James V. Cassella
Chief Development Officer & Senior Vice President
Ryan Lynch
Chief Accounting Officer & Controller
Justine E. Koenigsberg
VP-Corporate Communications & Investor Relations
Lynette Herscha
Secretary & General Counsel
Christine Boisclair
Vice President-Regulatory Affairs
Richard H. Aldrich
Chairman
Christine van Heek
Independent Director
Meghan M. Fitzgerald
Independent Director
Thomas G. Auchincloss
Independent Director
Wilfred E. Jaeger
Independent Director
Ronald W. Barrett
Independent Director
Peter Barton Hutt
Independent Director
Wendell D. Wierenga
Independent Director
| Address |
99 Hayden Avenue
Lexington Massachusetts 02421
United States
|
|
Employees
|
- |
| Website |
http://www.concertpharma.com |
| Updated |
07/08/2019 |
| Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. |
